日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FDG-PET/CT based small volume accelerated immuno chemoradiotherapy in locally advanced NSCLC (PACCELIO) - a randomized, open-label, multicenter phase II trial protocol

基于FDG-PET/CT的小体积加速免疫放化疗治疗局部晚期非小细胞肺癌(PACCELIO)——一项随机、开放标签、多中心II期试验方案

Shafie, Rami El; Willmann, Jonas; Gkika, Eleni; Schimek-Jasch, Tanja; Miederer, Matthias; Bozorgmehr, Farastuk; Griesinger, Frank; Manapov, Farkhad; Christopoulos, Petros; Hehr, Thomas; Hecht, Markus; Bütof, Rebecca; Stuschke, Martin; Guckenberger, Matthias; Schmid-Bindert, Gerald; Meiners, Jan; Herzer, Sascha; Hartmann, Sonja; Lamché, Joana; Rieken, Stefan; Nestle, Ursula

Incidental Pulmonary Nodules: What Should We Do in 2026?

偶然发现的肺结节:2026 年我们应该怎么做?

Schmid-Bindert, Gerald; Vogel-Claussen, Jens; Bollmann, Benjamin-Alexander; Lamché, Joana; Eichhorn, Martin E; Herth, Felix

When Stigma, Disclosure, and Access to Care Collide: An Ethical Reflection of mpox Vaccination Outreach

当污名、信息披露和就医途径发生冲突:对痘苗疫苗接种推广工作的伦理反思

Birch, Lane; Bindert, Adam; Macias, Susy; Luo, Ellis; Nwanah, Patrick; Green, Noel; Stamps, Jahari; Crooks, Natasha; Singer, Rebecca M; Johnson, Robin; Singer, Randi Beth

Incidental Pulmonary Nodules - What Do We Know in 2022

2022 年我们对偶然发现的肺结节了解多少?

Schmid-Bindert, Gerald; Vogel-Claussen, Jens; Gütz, Sylvia; Fink, Joana; Hoffmann, Hans; Eichhorn, Martin E; Herth, Felix J F

Design and Rationale of the HANSE Study: A Holistic German Lung Cancer Screening Trial Using Low-Dose Computed Tomography

HANSE 研究的设计和原理:一项采用低剂量计算机断层扫描的德国肺癌整体筛查试验

Vogel-Claussen, Jens; Lasch, Florian; Bollmann, Benjamin-Alexander; May, Katharina; Kuhlmann, Alexander; Schmid-Bindert, Gerald; Kaaks, Rudolf; Barkhausen, Jörg; Bohnet, Sabine; Reck, Martin

A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

一项随机、多中心II期研究,比较顺铂和培美曲塞两种给药方案在晚期或转移性非小细胞肺癌患者中的疗效、安全性和耐受性。

Metzenmacher, Martin; Kopp, Hans-Georg; Griesinger, Frank; Reinmuth, Niels; Sebastian, Martin; Serke, Monika; Waller, Cornelius Florian; Thomas, Michael; Eggert, Jochen; Schmid-Bindert, Gerald; Hoiczyk, Mathias; Christoph, Daniel Christian; Kimmich, Martin; Deuß, Burkhard; Seifert, Stephanie; Held, Swantje; Schuler, Martin; Herold, Thomas; Breitenbuecher, Frank; Eberhardt, Wilfried Ernst Erich

Eight Genome Sequences of Cluster BE1 Phages That Infect Streptomyces Species

感染链霉菌属的 BE1 簇噬菌体的八个基因组序列

Hughes, Lee E; Shaffer, Christopher D; Ware, Vassie C; Aguayo, Issac; Aziz, Rahat M; Bhuiyan, Swapan; Bindert, Isaac S; Calovich-Benne, Canyon K; Chapman, Jordyn; Donegan-Quick, Richard; Farooq, Amal; Garcia, Cynthia; Graham, Lee H; Green, Baylee Y; Kenna, Margaret A; Kneeream, Emily R; Laing, Christian E; Mageeney, Catherine M; Meridew, Sandra N; Mikolon, Abigail R; Morgan, Ryann E; Nayek, Subhayu; Olugbade, Idowu D; Pike, Kim C; Schlegel, Lauren E; Shishido, Taylor C; Suresh, Tara; Suri, Nikita; Weston Hafer, Kathleen; Garlena, Rebecca A; Russell, Daniel A; Cresawn, Steven G; Pope, Welkin H; Jacobs-Sera, Deborah; Hatfull, Graham F

First-line nivolumab (anti-PD-1) monotherapy in advanced NSCLC: the story of immune checkpoint inhibitors and "the sorcerers apprentice"

一线纳武利尤单抗(抗PD-1)单药治疗晚期非小细胞肺癌:免疫检查点抑制剂和“魔法师的学徒”的故事

Schmid-Bindert, Gerald; Jiang, Tao

EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods

EBUS-TBNA 在非小细胞肺癌患者常规获取的小活检样本中可提供最高的 RNA 产量,用于多种生物标志物检测——一项对三种不同微创取样方法的比较研究

Schmid-Bindert, Gerald; Wang, Yongsheng; Jiang, Hongbin; Sun, Hui; Henzler, Thomas; Wang, Hao; Pilz, Lothar R; Ren, Shengxiang; Zhou, Caicun

Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians

厄洛替尼在晚期非小细胞肺癌治疗中的应用:临床医生的最新进展

Wang, Yongsheng; Schmid-Bindert, Gerald; Zhou, Caicun